Goldman Sachs
JNCE

Goldman Sachs’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-42,922
Closed -$79.4K 5293
2023
Q1
$79.4K Sell
42,922
-83,824
-66% -$155K ﹤0.01% 4699
2022
Q4
$141K Sell
126,746
-34,773
-22% -$38.6K ﹤0.01% 4598
2022
Q3
$378K Sell
161,519
-43,114
-21% -$101K ﹤0.01% 4416
2022
Q2
$620K Sell
204,633
-187,283
-48% -$567K ﹤0.01% 4240
2022
Q1
$2.66M Sell
391,916
-328,529
-46% -$2.23M ﹤0.01% 3336
2021
Q4
$6.02M Buy
720,445
+46,519
+7% +$388K ﹤0.01% 2658
2021
Q3
$5.01M Buy
673,926
+509,577
+310% +$3.79M ﹤0.01% 2794
2021
Q2
$1.12M Buy
164,349
+13,038
+9% +$88.7K ﹤0.01% 3941
2021
Q1
$1.55M Buy
151,311
+115,764
+326% +$1.19M ﹤0.01% 3596
2020
Q4
$249K Sell
35,547
-2,540
-7% -$17.8K ﹤0.01% 4168
2020
Q3
$310K Sell
38,087
-18,785
-33% -$153K ﹤0.01% 3889
2020
Q2
$392K Sell
56,872
-23,090
-29% -$159K ﹤0.01% 3708
2020
Q1
$380K Sell
79,962
-31,004
-28% -$147K ﹤0.01% 3632
2019
Q4
$969K Sell
110,966
-25,823
-19% -$225K ﹤0.01% 3350
2019
Q3
$456K Buy
136,789
+43,114
+46% +$144K ﹤0.01% 3638
2019
Q2
$464K Buy
93,675
+3,374
+4% +$16.7K ﹤0.01% 3558
2019
Q1
$560K Sell
90,301
-4,921
-5% -$30.5K ﹤0.01% 3520
2018
Q4
$321K Sell
95,222
-6,516
-6% -$22K ﹤0.01% 3574
2018
Q3
$661K Buy
101,738
+17,742
+21% +$115K ﹤0.01% 3346
2018
Q2
$643K Buy
83,996
+7,216
+9% +$55.2K ﹤0.01% 3415
2018
Q1
$1.72M Buy
76,780
+14,993
+24% +$335K ﹤0.01% 2948
2017
Q4
$788K Sell
61,787
-53,175
-46% -$678K ﹤0.01% 3248
2017
Q3
$1.79M Buy
114,962
+45,314
+65% +$706K ﹤0.01% 2941
2017
Q2
$977K Buy
69,648
+57,336
+466% +$804K ﹤0.01% 3163
2017
Q1
$271K Buy
+12,312
New +$271K ﹤0.01% 3825